Wealthcare Advisory Partners’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-4,997
Closed -$212K 1481
2019
Q4
$212K Buy
4,997
+769
+18% +$30.5K 0.03% 290
2019
Q3
$162K Sell
4,228
-889
-17% -$34.2K 0.02% 308
2019
Q2
$199K Sell
5,117
-248
-5% -$9.43K 0.03% 270
2019
Q1
$213K Buy
5,365
+1,002
+23% +$39.6K 0.04% 233
2018
Q4
$159K Buy
4,363
+1,434
+49% +$56.4K 0.03% 239
2018
Q3
$125K Buy
2,929
+522
+22% +$21.2K 0.02% 294
2018
Q2
$93K Sell
2,407
-717
-23% -$26K 0.02% 337
2018
Q1
$109K Buy
3,124
+1,143
+58% +$40.7K 0.02% 263
2017
Q4
$72K Buy
+1,981
New +$71.6K 0.02% 314

Other funds holding BME

Wealthcare Advisory Partners's BME Position: Q1 2020 in Review

Wealthcare Advisory Partners sold out of BlackRock Health Sciences Trust (BME) in Q1 2020, closing a stake of 4,997 shares — an estimated $212K sold.

Wealthcare Advisory Partners first reported a position in BME in Q4 2017 and held it in 9 quarters. The position peaked at $213K in Q1 2019. 41 funds tracked by Wall St. Rank hold BME as of Q1 2020.

  • Wealthcare Advisory Partners reported no remaining BlackRock Health Sciences Trust position as of Q1 2020 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 4,997 BlackRock Health Sciences Trust shares in Q1 2020, an estimated $212K.
  • Wealthcare Advisory Partners first reported a position in BlackRock Health Sciences Trust in Q4 2017 and held it in 9 quarters.
  • Wealthcare Advisory Partners's BlackRock Health Sciences Trust position peaked at $213K in Q1 2019.
  • 41 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2020.

Based on Wealthcare Advisory Partners's 13F filing for Q1 2020, filed 29 Apr 2020.